Evaluation of a gastro-resistant pulsed release delivery system (Pulsincap) in humans

被引:22
作者
Wilson, CG
Bakhshaee, M
Stevens, HNE
Perkins, AC
Frier, M
Blackshaw, EP
Binns, JS
机构
[1] QUEENS MED CTR,DEPT MED PHYS,NOTTINGHAM NG7 2UH,ENGLAND
[2] SCHERER DDS LTD,CLYDEBANK,SCOTLAND
关键词
drug delivery; colon targeting; Pulsincap(TM); gastrointestinal transit;
D O I
10.3109/10717549709051893
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Using gamma scintigraphy, the behavior of a colon-targeted drug delivery system was followed in nine volunteers to ascertain the time and position in the gastrointestinal tract of a Pulsincap(TM) device when enteric coat dissolution and plug release occurred. Each subject received a single radiolabeled unit with either 50 mL (study 1) or 150 mL water (study 2) after fasting overnight. Anterior, posterior, and lateral views were recorded for up to 12 h after dosing and the images stored for analysis. Dissolution of the enteric coat was observed between 29 and 70 min after gastric emptying with release of the indium label in the small intestine. In the second study, separation of the body and plug of each device was evident in all six subjects after a mean time of 5.34 +/- 1.03 h (4.90 +/- 1.07 h after gastric emptying). In all eases, plug release occurred in the cecum or ascending colon. In one subject, visualization of separation of plug and body was delayed; at more than 10 h into the study separation was not evident; thereafter, at 10.5 h the separation was 5 cm. The data suggest that the device has excellent potential for positioned delivery of drugs into the gastrointestinal tract.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 21 条
[1]
COLONIC ABSORPTION OF HUMAN CALCITONIN IN MAN [J].
ANTONIN, KH ;
SAANO, V ;
BIECK, P ;
HASTEWELL, J ;
FOX, R ;
LOWE, P ;
MACKAY, M .
CLINICAL SCIENCE, 1992, 83 (05) :627-631
[2]
PATHOLOGICAL INFLUENCES ON COLONIC MOTILITY - IMPLICATIONS FOR DRUG DELIVERY [J].
BARROW, L ;
SPILLER, RC ;
WILSON, CG .
ADVANCED DRUG DELIVERY REVIEWS, 1991, 7 (01) :201-218
[3]
TRANSIT OF PHARMACEUTICAL DOSAGE FORMS THROUGH THE SMALL-INTESTINE [J].
DAVIS, SS ;
HARDY, JG ;
FARA, JW .
GUT, 1986, 27 (08) :886-892
[4]
AN ORAL PREPARATION TO RELEASE DRUGS IN THE HUMAN-COLON [J].
DEW, MJ ;
HUGHES, PJ ;
LEE, MG ;
EVANS, BK ;
RHODES, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :405-408
[5]
COLONIC RELEASE OF 5-AMINO SALICYLIC-ACID FROM AN ORAL PREPARATION IN ACTIVE ULCERATIVE-COLITIS [J].
DEW, MJ ;
RYDER, REJ ;
EVANS, N ;
EVANS, BK ;
RHODES, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :185-187
[6]
INVESTIGATION OF THE GASTROINTESTINAL TRANSIT AND INVIVO DRUG RELEASE OF ISOSORBIDE-5-NITRATE PELLETS [J].
FISCHER, W ;
BOERTZ, A ;
DAVIS, SS ;
KHOSLA, R ;
CAWELLO, W ;
SANDROCK, K ;
CORDES, G .
PHARMACEUTICAL RESEARCH, 1987, 4 (06) :480-485
[7]
COLON-SPECIFIC DRUG DELIVERY [J].
FRIEND, DR .
ADVANCED DRUG DELIVERY REVIEWS, 1991, 7 (01) :149-199
[8]
GILCHRIST PJ, 1995, P INT S CONTROL REL, V22, P206
[9]
HEALEY JNC, 1989, DRUG DELIVERY GASTRO, P83
[10]
REGION SELECTIVE DRUG-DELIVERY TO THE COLON [J].
HEBDEN, JM ;
WILSON, CG ;
SPILLER, RC ;
PERKINS, AC ;
GILCHRIST, PJ ;
BINNS, J ;
MILLER, CJ .
GASTROENTEROLOGY, 1995, 108 (04) :A613-A613